News

Dr. Matthew Galsky discusses the FDA approval of Imfinzi and chemo before and after surgery for muscle-invasive bladder ...
Overall, rates of new cancer diagnoses and cancer-related deaths have declined. Between 2018 and 2022, cancer death rates have decreased by 1.7% each year for men and 1.3% for women, the report stated ...
Investigators compared oncologic outcomes among patients with tumors in the bladder only vs in the bladder neck/urethra.
Steam may be more powerful than you think. It smooths clothes and kills germs, but now doctors are testing it against cancer.
Bavencio improved survival in patients with bladder cancer, irrespective of diabetes status, according to an analysis of the ...
Metastatic castration-resistant prostate is an advanced form of the cancer that’s incurable. Learn about treatment options ...
The following is a summary of “Comparison of hyperthermic intravesical chemotherapy using pirarubicin and Bacillus ...
Metastatic castration-resistant prostate cancer (mCRPC) treatment can involves chemotherapy, radiation, and more. Find the ...
Imfinzi is approved in combination with gemcitabine and cisplatin as a neoadjuvant treatment for muscle-invasive bladder cancer (MIBC), a type of bladder cancer that has spread into the muscle ...
A team has developed a new way to quickly find personalized treatments for young cancer patients, by growing their tumors in chicken eggs and analyzing their proteins. The team has combined these ...
Imfinzi-based regimen cuts the risk of disease progression, recurrence, or death by 32% in muscle-invasive bladder cancer. Calquence combo reduced disease progression or death risk by 27% in ...